Regeneron Pharmaceuticals (REGN)
Net Income Growth
-6.81%
Quarterly · Period ending:
REGN Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-6.81%period ending
Latest reported-6.81%period ending
REGN Quarterly Net Income YoY % (-37.50% → -6.81%)
Year-over-year change
High-resolution chart · PNG
REGN net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -403.3593% | |
| -78.1498% | |
| -595.6429% | |
| 34.4694% | |
| 62.2179% | |
| 17.7753% | |
| 74.5455% | |
| -250% | |
| -471.4286% | |
| -134.2105% | |
| -1,200% | |
| 26.3158% | |
| 148.8372% | |
| 35.5932% | |
| 106.1728% | |
| 78.6517% | |
| 43.4211% | |
| 24.359% | |
| -3.8462% | |
| -25.3521% | |
| -72.7273% | |
| -85.7143% | |
| -34.4828% | |
| -77.5% | |
| 56.8627% | |
| 60.7477% | |
| 49.5652% | |
| 58.3333% | |
| -8.5106% | |
| -15.0538% | |
| -79.6875% | |
| -65.5172% | |
| -154.0541% | |
| -181.8182% | |
| -204.7619% | |
| -544.4444% | |
| -1,133.3333% | |
| -200% | |
| -133.3333% | |
| -12.5% | |
| 62.5% | |
| -37.5% |